| MM-102 |
MM-102 |
1417329-24-8 |
| RI-2 |
化合物RI-2 |
1417162-36-7 |
| TG6-10-1 |
TG6-10-1 |
1415716-58-3 |
| JNK-IN-8 |
JNK-IN-8 |
1410880-22-6 |
| Tazemetostat (EPZ-6438) |
EPZ-6438 |
1403254-99-8 |
| GSK2879552 |
GSK2879552 |
1401966-69-5 |
| BS-181 HCl |
BS181 |
1397219-81-6 |
| G007-LK |
G007-LK |
1380672-07-0 |
| CO-1686 |
CO1686 |
1374640-70-6 |
| BRD4770 |
2-苯甲酰胺基-1-(3-苯丙基)-1H-苯并[D]咪唑-5-羧酸甲酯 |
1374601-40-7 |
| GSK2636771 |
GSK2636771 |
1372540-25-4 |
| ON123300 |
8-环戊基-7,8-二氢-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈 |
1357470-29-1 |
| Naloxegol Oxalate |
聚乙二醇纳诺醇 |
1354744-91-4 |
| XL765 |
XL765 |
1349796-36-6 |
| N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-3-methyl-6-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide |
化合物GSK503 |
1346572-63-1 |
| S)-1-(sec-butyl)-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-3-Methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxaMide |
GSK126 |
1346574-57-9 |
| 2-(2H-benzo[b][1,4]oxazin-4(3H)-yl)-N-benzyl-5,6,7,8-tetrahydroquinazolin-4-amine |
ML241 |
1346528-06-0 |
| N-(5-(1-(2,6-dichlorophenyl)-3-(difluoroMethyl)-1H-pyrazol-5-yl)thiazol-2-yl)isobutyraMide |
BMS-5 |
1338247-35-0 |
| ML224 |
CS-1585 |
1338824-21-7 |
| N-(5-(1-(2,6-dichlorophenyl)-3-(difluoroMethyl)-1H-pyrazol-5-yl)thiazol-2-yl)cyclopropanecarboxaMide |
BMS-3 |
1338247-30-5 |
